Adebrelimab [CAS 2247114-85-6]
Partner: MedChemexpress LLC
| CAS No: | 2247114-85-6 |
| Applications: | Cancer-programmed cell death |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Adebrelimab] |
| Purity: | 97.84 |
| Description: | Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC)[1][2]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
